Nolan, Craig

Publications

Sort by

Co-Author Network

selected publications

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 123
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. Cancer discovery. 2017 Academic Article GET IT
Times cited: 243
The confused oncologic patient: a rational clinical approach. Current opinion in neurology. 2016 Review GET IT
Times cited: 8
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 78
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro-oncology. 2015 Academic Article GET IT
Times cited: 139
Neurologic complications of chemotherapy and radiation therapy. Continuum (Minneapolis, Minn.). 2015 Review GET IT
Times cited: 29
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Academic Article GET IT
Times cited: 225
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 78
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro-oncology. 2014 Academic Article GET IT
Times cited: 182
Intramedullary spinal cord and leptomeningeal metastases from intracranial low-grade oligodendroglioma. 2014 GET IT
Times cited: 4
Bevacizumab for acute neurologic deterioration in patients with glioblastoma. CNS oncology. 2013 Academic Article GET IT
Times cited: 6
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-oncology. 2012 Academic Article GET IT
Times cited: 87
Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer. Journal of neuro-oncology. 2010 Academic Article GET IT
Times cited: 91
Myelopathies in patients with cancer. Archives of neurology. 2010 Review GET IT
Times cited: 33
Pearls: primary brain tumors. Seminars in neurology. 2010 Academic Article GET IT
Times cited: 1
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 155
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. Journal of neuro-oncology. 2007 Academic Article GET IT
Times cited: 41
Salvage temozolomide for prior temozolomide responders. Cancer. 2005 Academic Article GET IT
Times cited: 76
Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. Journal of neuro-oncology. 2005 Review GET IT
Times cited: 59
Leptomeningeal metastases from leukemias and lymphomas. Cancer treatment and research. 2005 Review GET IT
Times cited: 15

more ...

less ...

Background

education and training

M.D., University of Chicago Pritzker School of Medicine 1992
B.A., University of Chicago 1988

Contact

full name

Craig Nolan

VIVO Weill Cornell Medical College

Craig Nolan Assistant Professor of Clinical Neurology

Publications

selected publications

Background

education and training

Contact

full name